A
Arbutus Biopharma (ABUS)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Arbutus Biopharma (ABUS)
Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company. The Company is engaged in discovering, developing and commercializing cure for people with chronic hepatitis B virus (HBV) infection. Its product pipeline is focused on find... Read more
- USD3.29
- USD3.37
- USD3.22
- USD4.73
- 1.90%
- 6M
- 640.24k
- 886.58k
- 687M
- 2.71
- 9.90%
Stock News
2 hours ago
FAA weighs reducing Newark flights after hundreds of disruptions
CNBC
3 hours ago
Lutnick says 10% baseline tariff will stick around for "foreseeable future"
CNBC
3 hours ago
The ‘most important consumer earnings report of the season’ lands this week
MarketWatch
4 hours ago
People are feeling lousy about work. The internet's career advice expert has some tips
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
